Skip to main content
. 2022 Nov 17;13:1016696. doi: 10.3389/fgene.2022.1016696

TABLE 4.

Heterogeneity and horizontal pleiotropy check.

EP OC Heterogeneity check 1 Heterogeneity check 2 Horizontal pleiotropy check
Q P Q P Intercept SE P
BPH BLCA 7.613744 0.47208 5.508447 0.598165 -0.00052 0.000357 0.190081
BLCA BPH 34.51226 0.00056 33.85226 0.000382 0.000309 0.000667 0.652321

Benign prostate hyperplasia, BPH; bladder cancer, BLCA; exposure, EP; outcome, OC; Heterogeneity check one was performed by IVW, method; Cochran’s Q value, Q; Heterogeneity check two was performed by MR-Egger method; Horizontal pleiotropy test was performed by MR-Egger method; inverse variance weighted, IVW; standard error, SE.